Christian Schumann Selected Research

Christian Schumann Research Topics

Disease

22	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 03/2006
18	Neoplasms (Cancer) 11/2023 - 05/2004
9	Exanthema (Rash) 05/2021 - 01/2010
6	Disease Progression 01/2022 - 07/2006
5	Pneumonia (Pneumonitis) 01/2022 - 08/2007
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2006
4	Lung Neoplasms (Lung Cancer) 11/2023 - 11/2009
4	COVID-19 01/2022 - 07/2020
4	Infections 08/2021 - 08/2006
3	Adenocarcinoma 10/2022 - 11/2015
3	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 07/2020
2	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2009
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2020 - 06/2015
2	Dyspnea (Shortness of Breath) 12/2019 - 12/2011
2	Neutropenia 06/2016 - 12/2011
2	Pulmonary Hypertension 06/2015 - 09/2010
2	Asthma (Bronchial Asthma) 10/2012 - 10/2010
2	Sepsis (Septicemia) 03/2012 - 01/2006
2	Hemorrhage 04/2010 - 05/2004
1	Acute Kidney Injury (Acute Renal Failure) 04/2023
1	Adenocarcinoma of Lung 10/2022
1	Brain Neoplasms (Brain Tumor) 02/2022
1	Fibrosis (Cirrhosis) 08/2021
1	Superinfection 08/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Emphysema 01/2021
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Autoimmune Diseases (Autoimmune Disease) 12/2020
1	Virus Diseases (Viral Diseases) 07/2020
1	Edema (Dropsy) 01/2020
1	Mucositis 01/2020
1	Rupture 09/2018
1	Aortic Coarctation 01/2017
1	Thrombocytopenia (Thrombopenia) 06/2016
1	Sarcoma (Soft Tissue Sarcoma) 11/2015
1	Acne Vulgaris 07/2015

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 05/2021 - 10/2012
6	Biomarkers (Surrogate Marker)IBA 05/2021 - 01/2006
5	Cisplatin (Platino)FDA LinkGeneric 01/2017 - 03/2015
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2020 - 01/2010
4	Pemetrexed (MTA)FDA Link 01/2017 - 03/2015
4	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 03/2006
3	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2021
3	C-Reactive ProteinIBA 01/2022 - 07/2020
3	salicylhydroxamic acid (SHAM)IBA 01/2022 - 12/2019
3	necitumumabIBA 06/2016 - 03/2015
3	CytokinesIBA 07/2014 - 01/2006
2	Docetaxel (Taxotere)FDA Link 10/2022 - 12/2011
2	NivolumabIBA 02/2022 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2022 - 07/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2021 - 12/2011
2	Monoclonal AntibodiesIBA 05/2021 - 11/2015
2	PlatinumIBA 01/2021 - 01/2021
2	Panitumumab (Vectibix)FDA Link 05/2017 - 11/2015
2	Gemcitabine FDA Link 06/2016 - 07/2015
2	Tyrosine Kinase InhibitorsIBA 03/2016 - 08/2015
2	AntibodiesIBA 07/2015 - 08/2006
2	EnzymesIBA 07/2014 - 07/2007
2	Vinorelbine (Navelbine)FDA LinkGeneric 06/2013 - 05/2008
2	Mitomycin (Mitomycin-C)FDA LinkGeneric 06/2013 - 05/2008
2	Omalizumab (Xolair)FDA Link 10/2012 - 10/2010
2	LipopolysaccharidesIBA 03/2012 - 08/2007
1	sotorasibIBA 02/2024
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Ribosomal RNAIBA 11/2023
1	nintedanibIBA 10/2022
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2022
1	IgG Receptors (Fc gamma RI)IBA 08/2021
1	MicroRNAs (MicroRNA)IBA 05/2021
1	Peptide Hydrolases (Proteases)FDA Link 01/2021
1	B7-H1 AntigenIBA 01/2021
1	Antimicrobial PeptidesIBA 12/2020
1	durvalumabIBA 12/2020
1	emibetuzumabIBA 01/2020
1	Cholinergic Agents (Cholinergics)IBA 01/2020
1	Cetuximab (Erbitux)FDA Link 05/2017
1	Gefitinib (Iressa)FDA Link 05/2017
1	LY2603618IBA 01/2017
1	Bevacizumab (Avastin)FDA Link 01/2017
1	Checkpoint Kinase 1IBA 01/2017
1	Coenzyme A (CoA)IBA 01/2017
1	Growth Factor ReceptorsIBA 11/2015
1	AfatinibIBA 10/2015
1	Indicators and Reagents (Reagents)IBA 06/2015

Therapy/Procedure

23	Therapeutics 10/2023 - 05/2004
13	Drug Therapy (Chemotherapy) 10/2023 - 05/2008
3	Blood Component Removal (Apheresis) 01/2022 - 07/2020
3	Denervation 01/2022 - 12/2019
3	Radiofrequency Ablation 12/2019 - 12/2011
2	Immunotherapy 10/2023 - 01/2021
2	Chemoradiotherapy 10/2023 - 12/2020
2	Combination Drug Therapy (Combination Chemotherapy) 06/2013 - 05/2008
1	Continuous Renal Replacement Therapy 04/2023
1	Patient Admission (Patient Admissions) 01/2022
1	Pneumonectomy (Lung Volume Reduction) 01/2021
1	Stents 09/2018
1	Endovascular Aneurysm Repair 09/2018
1	Adjuvant Chemotherapy 01/2016